{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-009381","form_type":"8-K","ticker":null,"cik":"0001848861","company_name":"Healthcare AI Acquisition Corp.","filed_at":"2023-12-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.025012+00:00","generated_at":"2026-06-07T06:30:09.275080+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Healthcare AI Acquisition Corp. announces board and CEO change effective Dec. 28, 2023","bullets":["Jiande Chen appointed CEO and Chairman; Zikang Wu resigns as CEO and director.","Xiaocheng Peng appointed permanent CFO and non-independent director.","Four new directors appointed: Jiande Chen, Nat Y Chan, Stefan Dodov, Manuel C. Menendez III.","Outgoing directors: Zikang Wu, Hao Tian, Yuerong Tan, Zixun Jin.","Changes effective Dec. 28, 2023, following required 14f-1 waiting period."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-009381","json":"https://secwatch.observer/filing/0001477932-23-009381.json","markdown":"https://secwatch.observer/filing/0001477932-23-009381.md","text":"https://secwatch.observer/filing/0001477932-23-009381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/haia_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T06:30:09.275080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"02b5163b84","claim":"Xiaocheng Peng was appointed as Chief Financial Officer at Healthcare AI Acquisition Corp..","evidence_excerpt":"Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"18c2d878a3","claim":"Nat Y Chan was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the \"New Directors\") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the \"Outgoing Directors\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2a43427356","claim":"Yuerong Tan resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the \"New Directors\") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the \"Outgoing Directors\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3c0fc618bd","claim":"Jiande Chen was appointed as Chairman of the Board at Healthcare AI Acquisition Corp..","evidence_excerpt":"Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"3eb9f63e55","claim":"Zikang Wu resigned as Chief Executive Officer at Healthcare AI Acquisition Corp..","evidence_excerpt":"Zikang Wu shall resign as chief executive officer, to be effective upon the expiration of all applicable waiting periods under Section 14(f) of the Exchange Act and Rule 14f-1 thereunder.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"ad7b55d11b","claim":"Hao Tian resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the \"New Directors\") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the \"Outgoing Directors\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"af3110c3ce","claim":"Stefan Dodov was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the \"New Directors\") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the \"Outgoing Directors\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b3f303a332","claim":"Manuel C. Menendez III was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the \"New Directors\") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the \"Outgoing Directors\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bbd8547c88","claim":"Jiande Chen was appointed as Chief Executive Officer at Healthcare AI Acquisition Corp..","evidence_excerpt":"Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"c9303dc55c","claim":"Zikang Wu resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the \"New Directors\") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the \"Outgoing Directors\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d5c4663909","claim":"Jiande Chen was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the \"New Directors\") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the \"Outgoing Directors\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d9ac708259","claim":"Zixun Jin resigned as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"The Company designated each of Jiande Chen, Nat Y Chan, Stefan Dodov and Manuel C. Menendez III (the \"New Directors\") to fill the vacancies to be left by departing directors Zikang Wu, Hao Tian, Yuerong Tan and Zixun Jin (the \"Outgoing Directors\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fe61f93d4e","claim":"Xiaocheng Peng was appointed as Director at Healthcare AI Acquisition Corp..","evidence_excerpt":"Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1848861/000147793223009381/0001477932-23-009381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}